Remdesivir for the treatment of COVID-19-Reference-Cited by-同舟云学术

Remdesivir for the treatment of COVID-19

Published:2021-08-05 Issue:8 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ansems Kelly¹,Grundeis Felicitas²,Dahms Karolina¹,Mikolajewska Agata³,Thieme Volker²,Piechotta Vanessa⁴,Metzendorf Maria-Inti⁵,Stegemann Miriam³,Benstoem Carina¹,Fichtner Falk²

Affiliation:

1. Department of Intensive Care Medicine; Medical Faculty, RWTH Aachen University; Aachen Germany

2. Department of Anaesthesiology and Intensive Care; University of Leipzig Medical Center; Leipzig Germany

3. Department of Infectious Diseases and Respiratory Medicine; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin; Berlin Germany

4. Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany

5. Cochrane Metabolic and Endocrine Disorders Group; Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf; Düsseldorf Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference204 articles.

1. Remdesivir for the treatment of COVID-19 - final report;New England Journal of Medicine,2020

2. Beigel JH Dodd LE Remdesivir for the treatment of COVID-19 - preliminary report New England Journal of Medicine 10.1056/NEJMc2022236 32649078

3. Remdesivir for the treatment of COVID-19 - preliminary report;Beigel;New England Journal of Medicine,2020

4. Epstein M Avoiding the termination of ACTT European Heart Journal 2020 10.1093/eurheartj/ehaa546

5. A multicenter, adaptive, randomised blinded controlled trial of the safety and efficacy of investigational therapeutics for the treatment of COVID-19 in hospitalised adults - version for European Union/United Kingdom sites www.clinicaltrialsregister.eu/ctr-search/search?query=EUCTR2020-001052-18-DE

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Real-World EMR Data to Rapidly Evaluate Treatment Effects of Existing Drugs for Emerging Infectious Diseases: Remdesivir for COVID-19 Treatment as an Example;Statistics in Biosciences;2024-01-02

2. Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies;BMJ Medicine;2024-01

3. Remdesivir may hinder the function of Recombination Activating Gene-1 (RAG1);Medical Hypotheses;2024-01

4. An umbrella review on treatments and therapeutic options for COVID-19;Russian Journal of Infection and Immunity;2023-11-30

5. Early versus late tracheostomy in critically ill COVID-19 patients;Cochrane Database of Systematic Reviews;2023-11-20